Brinker upgraded, Coinbase downgraded: Wall Street's top analyst calls

Core Insights - The article summarizes significant research calls from Wall Street, highlighting upgrades and downgrades of various companies that could impact investor decisions [1] Upgrades - Wolfe Research upgraded Inspire Medical (INSP) to Outperform from Peer Perform with a price target of $180, citing a "surprise" 50% Medicare reimbursement increase as a positive factor for the stock [2] - UBS upgraded Cummins (CMI) to Neutral from Sell with a price target of $500, increased from $350, indicating a balanced risk/reward as the truck cycle is expected to bottom in 2026 [2] - Raymond James upgraded CDW (CDW) to Strong Buy from Outperform with a price target of $185, noting that easing cost headwinds may lead to growth acceleration [3] - Citi upgraded Brinker (EAT) to Buy from Neutral with a price target of $176, up from $144, as the cost environment improves with reduced food tariffs in Brazil, potentially boosting sales through fiscal 2026 [3] - UBS upgraded Applied Materials (AMAT) to Buy from Neutral with a price target of $285, raised from $250, based on a more optimistic outlook for wafer fab equipment spending in 2026 and 2027 [4] Downgrades - Argus downgraded Coinbase (COIN) to Hold from Buy with no price target, citing the stock's high valuation at 39 times expected forward earnings compared to lower multiples of other exchanges [5] - Rothschild & Co Redburn downgraded Estee Lauder (EL) to Sell from Neutral with a price target of $70, down from $83, due to the need for deeper investment despite improving sales growth [5] - Canaccord downgraded Exact Sciences (EXAS) to Hold from Buy with a price target of $105, up from $85, following the announcement of an acquisition agreement by Abbott (ABT) at $105 per share [5] - Northland downgraded Green Dot (GDOT) to Market Perform from Outperform with a price target of $14.25, down from $18, after the announcement of complex strategic transactions separating its fintech and bank operations [5] - Barclays downgraded Camden Property (CPT) to Equal Weight from Overweight with a price target of $118, down from $127, as its total return profile is now seen as average compared to the apartment REIT sector [5]